Scrip
Clinica
Scrip Regulatory Affairs
Scrip Clinical Research
AnimalPharm
Email ID
Password
Forgotten your password?
Sign me in automatically next time
Advanced Search
Home
Therapy Sector
Generics
Business
Policy & Regulation
Research & Development
International
Product Approvals
|
Clinical Trials
|
Product Filings
|
Product Safety
|
Preclinical
|
Product Delays
|
Research & Development - Product Approvals
About Us
Getting Started
Subscribe
Free Trial
Advertise
Awards
White Papers
Executive Briefing
Classifieds
Recruitment
JOB OF THE WEEK
Promote your vacancy here
SCRIP's ONLINE DIRECTORY
Classified ads
LATEST NEWS
New Japanese recommendations include Humira for psoriasis
22 October 2009
Betanis, Tradjenta and Onbrez priced and set for launch in J...
BMS to appeal NICE 'no' on Orencia in RA...
Cervarix, Prevenar and Januvia among new Japanese approvals
19 October 2009
Cervarix and Prevenar move closer to approval in Japan
01 September 2009
Japan recommends its first biosimilar, Sandoz's somatropin
04 June 2009
GSK's anticancer Tykerb among new Japanese recommendations
16 March 2009
>> More News...
LATEST ANALYSIS
2010 Scrip 100 - EMA showing it has nothing to hide
09 December 2009
2010 Scrip 100 - Bursting the obesity bubble
09 December 2009
Market Insight - Making rare diseases rarer
17 February 2009
>> More Analysis...
REFINE BY
COMPANY/ORGANISATION
PFIZER
NOVARTIS
GLAXOSMITHKLINE
SANOFI-AVENTIS
CONDITION
CANCER
PAIN
DIABETES
ARTHRITIS
GEOGRAPHY
JAPAN
GERMANY
INDIA
CANADA
DRUG
BEVACIZUMAB
SIMVASTATIN
RITUXIMAB
AMLODIPINE